Cargando…
Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study
Background: The advent of monoclonal antibodies (mAbs) has revolutionized the management of many immune-mediated diseases such as inflammatory bowel disease (IBD). Infliximab and adalimumab were the first mAbs approved for the management of IBD, and are still commonly prescribed for the treatment of...
Autores principales: | Alharbi, Othman, Aljebreen, Abdulrahman M., Azzam, Nahla A., Almadi, Majid A., Saeed, Maria, HajkhderMullaissa, Baraa, Asiri, Hassan, Almutairi, Abdullah, AlRuthia, Yazed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321911/ https://www.ncbi.nlm.nih.gov/pubmed/35887921 http://dx.doi.org/10.3390/jcm11144157 |
Ejemplares similares
-
Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019) -
Prevalence and Characteristics of Colonic Polyps and Adenomas in 2654 Colonoscopies in Saudi Arabia
por: Almadi, Majid A., et al.
Publicado: (2014) -
Rate and risk factors of postoperative endoscopic recurrence of moderate- to high-risk Crohn's disease patients - A real-world experience from a Middle Eastern cohort
por: Azzam, Nahla, et al.
Publicado: (2022) -
Clinical Epidemiology and Phenotypic Characteristics of Crohn's Disease in the Central Region of Saudi Arabia
por: Aljebreen, Abdulrahman M., et al.
Publicado: (2014) -
Predictors of Survival Among Colorectal Cancer Patients in a Low Incidence Area
por: Azzam, Nahla, et al.
Publicado: (2020)